InvestorsHub Logo
Followers 10
Posts 3104
Boards Moderated 1
Alias Born 04/20/2001

Re: MCArmel1 post# 13

Thursday, 07/24/2014 11:38:42 AM

Thursday, July 24, 2014 11:38:42 AM

Post# of 51
8:05 am Dr Pepper Snapple beats by $0.16, reports revs in-line; raises FY14 EPS, reaffirms FY14 revs guidance (DPS) : Reports Q2 (Jun) earnings of $1.06 per share, excluding non-recurring items, $0.16 better than the Capital IQ Consensus Estimate of $0.90; revenues rose 1.2% year/year to $1.63 bln vs the $1.62 bln consensus.


•For the quarter, reported net sales increased 1% as a sales volume increase, favorable product and package mix and pricing were partially offset by higher discounts and 1 percentage point of unfavorable foreign currency.
Co issues guidance for FY14, raises EPS to $3.43-3.51 from $3.38-3.46 vs. $3.47 Capital IQ Consensus; reaffrims FY14 revs flat to +1% to $6.0-6.06 bln vs. $6.05 bln Capital IQ Consensus Estimate. The company continues to expect full-year reported net sales to be flat to up 1%. The company is raising its guidance and now expects Core EPS to be in the $3.43 to $3.51 range. Packaging and ingredient costs, including LIFO impacts, are expected to decrease COGS by 2% on a constant volume/mix basis. The company expects its core tax rate to be approximately 35.5%. The company continues to expect capital spending to be ~3% of net sales. The company expects to repurchase $375 million to $400 million of its common stock.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KDP News